These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 17285546)

  • 1. [A study on the expression of CASP9 gene and its polymorphism distribution in non-small cell lung cancer].
    Lou Y; Fang CQ; Li JH
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Feb; 24(1):59-62. PubMed ID: 17285546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Correlation of matrix metalloproteinase-3 polymorphism to genetic susceptibility and lymph node metastasis of non-small cell lung cancer].
    Fang SM; Jin X; Li Y; Wang R; Guo W; Wang N; Zhang JH
    Ai Zheng; 2005 Mar; 24(3):305-10. PubMed ID: 15757531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. No association between the C-1562T polymorphism in the promoter of matrix metalloproteinase-9 gene and non-small cell lung carcinoma.
    Wang Y; Fang S; Wei L; Wang R; Jin X; Wen D; Li Y; Guo W; Wang N; Zhang J
    Lung Cancer; 2005 Aug; 49(2):155-61. PubMed ID: 15949868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic polymorphism and gene expression of microsomal epoxide hydrolase in non-small cell lung cancer.
    Lin TS; Huang HH; Fan YH; Chiou SH; Chow KC
    Oncol Rep; 2007 Mar; 17(3):565-72. PubMed ID: 17273734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
    Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
    Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The involvement of genetic polymorphism of IL-10 promoter in non-small cell lung cancer.
    Shih CM; Lee YL; Chiou HL; Hsu WF; Chen WE; Chou MC; Lin LY
    Lung Cancer; 2005 Dec; 50(3):291-7. PubMed ID: 16122836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China.
    Fang S; Jin X; Wang R; Li Y; Guo W; Wang N; Wang Y; Wen D; Wei L; Zhang J
    Carcinogenesis; 2005 Feb; 26(2):481-6. PubMed ID: 15528217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of TNF-alpha polymorphism with susceptibility to and severity of non-small cell lung cancer.
    Shih CM; Lee YL; Chiou HL; Chen W; Chang GC; Chou MC; Lin LY
    Lung Cancer; 2006 Apr; 52(1):15-20. PubMed ID: 16476505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of EcoRI polymorphism of the metastasis-suppressor gene NME1 with susceptibility to and severity of non-small cell lung cancer.
    Hsieh YS; Lee YL; Yang SF; Yang JS; Chen W; Chen SC; Shih CM
    Lung Cancer; 2007 Nov; 58(2):191-5. PubMed ID: 17688968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promoter-hypermethylation associated defective expression of E-cadherin in primary non-small cell lung cancer.
    Wang G; Hu X; Lu C; Su C; Luo S; Luo ZW
    Lung Cancer; 2008 Nov; 62(2):162-72. PubMed ID: 18468719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The functional polymorphism in the matrix metalloproteinase-7 promoter increases susceptibility to esophageal squamous cell carcinoma, gastric cardiac adenocarcinoma and non-small cell lung carcinoma.
    Zhang J; Jin X; Fang S; Wang R; Li Y; Wang N; Guo W; Wang Y; Wen D; Wei L; Dong Z; Kuang G
    Carcinogenesis; 2005 Oct; 26(10):1748-53. PubMed ID: 15930031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The expression of the CD44 variant exon 6 is associated with lymph node metastasis in non-small cell lung cancer.
    Miyoshi T; Kondo K; Hino N; Uyama T; Monden Y
    Clin Cancer Res; 1997 Aug; 3(8):1289-97. PubMed ID: 9815811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.
    Zhao ZH; Wang SF; Yu L; Wang J; Chang H; Yan WL; Zhang J; Fu K
    Lung Cancer; 2008 Oct; 62(1):113-9. PubMed ID: 18550205
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ets2 binding site single nucleotide polymorphism at the hTERT gene promoter--effect on telomerase expression and telomere length maintenance in non-small cell lung cancer.
    Hsu CP; Hsu NY; Lee LW; Ko JL
    Eur J Cancer; 2006 Jul; 42(10):1466-74. PubMed ID: 16737810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of MMP-2 and MMP-9 promoter polymorphisms on gene expression and clinical outcome of non-small cell lung cancer.
    Rollin J; Régina S; Vourc'h P; Iochmann S; Bléchet C; Reverdiau P; Gruel Y
    Lung Cancer; 2007 May; 56(2):273-80. PubMed ID: 17208328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship among telomerase activity, telomerase RNA and telomerase catalytic subunit gene expression and their significance in non small-cell lung cancer].
    Wang J; Liu X; Jiang W
    Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):289-92. PubMed ID: 11783109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of functional genetic polymorphism (-590C/T) in non-small cell lung cancer (NSCLC) development: the paradoxal role of IL-4.
    Gomes M; Coelho A; Araújo A; Teixeira AL; Catarino R; Medeiros R
    Gene; 2012 Aug; 504(1):111-5. PubMed ID: 22583827
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CYP450 polymorphisms predict clinic outcomes to vinorelbine-based chemotherapy in patients with non-small-cell lung cancer.
    Pan JH; Han JX; Wu JM; Sheng LJ; Huang HN
    Acta Oncol; 2007; 46(3):361-6. PubMed ID: 17450472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stromal cell-derived factor-1 (SDF-1) gene and susceptibility of Iranian patients with lung cancer.
    Razmkhah M; Doroudchi M; Ghayumi SM; Erfani N; Ghaderi A
    Lung Cancer; 2005 Sep; 49(3):311-5. PubMed ID: 15955592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Expression and mutation of Fas-associated death domain (FADD) gene in non-small cell lung cancer].
    Yang Q; Zhu RQ; Fang Z; Xia D; Diao LM; Liu MQ
    Ai Zheng; 2005 Mar; 24(3):321-6. PubMed ID: 15757534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.